论文部分内容阅读
本文报告我科1985年5月～1987年5月用EBVD方案治疗何杰金氏病20例和CEOP方案治疗非何杰金氏淋巴瘤27例的近期疗效和毒性反应。全组病例均经病理证实,何杰金氏病20例,(其中淋巴细胞为主型4例,结节硬化型2例,混合细胞型13例,未分型1例)。
This article reports the short-term efficacy and toxicity of the EBVD regimen for the treatment of Hodgkin’s disease in 20 cases and the CEOP regimen in 27 cases of non-Hodgkin’s lymphoma from May 1985 to May 1987. All cases were confirmed by pathology, Hodgkin’s disease in 20 cases (including 4 cases of lymphocyte predominance, 2 cases of nodular sclerosis, mixed cell type 13 cases, 1 case without classification).